You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
McKinsey
Harvard Business School
Colorcon
Johnson and Johnson

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

Litigation for COMPLERA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Court Litigation for COMPLERA

Glossary
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,043,230   Start Trial   Start Trial 2020-01-14 2020-01-28 15:0002 Antitrust Litigation District Court, S.D. Florida Plaintiff   Start Trial
6,043,230   Start Trial   Start Trial 2016-07-06 2018-04-25 Court of Appeals for the Federal Circuit   Start Trial
6,043,230 Staley v. Gilead Sciences, Inc.   Start Trial 2019-05-14 15:1 Antitrust Litigation District Court, N.D. California Both   Start Trial
6,043,230   Start Trial   Start Trial 2019-05-20 15:1 Antitrust Litigation District Court, N.D. California Plaintiff   Start Trial
6,043,230 Gilead Sciences, Inc. v. Merck & Co, Inc.   Start Trial 2013-08-30 2016-06-06 28:1331 Fed. Question District Court, N.D. California Both   Start Trial
6,043,230   Start Trial   Start Trial 2019-05-20 15:1 Antitrust Litigation District Court, N.D. California Plaintiff   Start Trial
6,642,245 GILEAD SCIENCES, INC. v. Mylan Inc.   Start Trial 2014-06-09 2015-11-02 28:1338 Patent Infringement District Court, N.D. West Virginia None   Start Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Subscribe to access the full database, or Start Trial

Patent Trial and Appeal Board Cases for COMPLERA

Glossary
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,922,695 Mylan Pharmaceuticals Inc.   Start Trial 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review   Start Trial 12-09-2014 MURTY ARIMILLI   Start Trial
5,935,946 MYLAN PHARMACEUTICALS INC.   Start Trial 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review   Start Trial 12-17-2014 JOHN MUNGER   Start Trial
5,977,089 Mylan Pharmaceuticals Inc.   Start Trial 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review   Start Trial 12-09-2014 MURTY ARIMILLI   Start Trial
6,043,230 Mylan Pharmaceuticals Inc.   Start Trial 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review   Start Trial 12-09-2014 MURTY ARIMILLI   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Johnson and Johnson
AstraZeneca
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group